Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67
Michael Ehlers left his CEO role at Ascidian Therapeutics, the exon editing company he co-founded, to run R&D at the AI biotech Formation Bio. It’s not often that biotech executives leave ...
July 24, 2026 07:00 AM EDT Peer Review Michael Ehlers joins Formation Bio to lead R&D; Black Diamond co-founder dies at 67 Alex Hoffman Copy Chief and News Editor Lei Lei Wu News Reporter Kyle LaHucik Biotech Correspondent Michael Ehlers left his CEO role at Ascidian Therapeutics, the exon editing company he co-founded, to run R&D at the AI … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that